COVAXIN Current Affairs, GK & News
Covishield-jabbed to be allowed into 8 European countries
Eight European Union states included Covishield in list of vaccines approved to enter into the region. Key Points Covishield was allowed in 8 EU counties after India warned of retaliation when none of its vaccines were added to ‘Green Pass’. Which 8 countries allowed entry? Eight countries include Germany, Austria, Slovenia, Iceland, Greece, Spain, Ireland ..
Month: Current Affairs - July, 2021
Category: International Current Affairs
Topics: COVAXIN • COVISHILED • COWIN • CoWIN Platform • EU’s Digital Green Pass • European Union’s Green Pass list
ZyCoV-D: World’s first DNA-based Vaccine
Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the world’s first DNA-based vaccine. With this, the number of vaccines available in the country will increase to 4. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin and ..
Month: Current Affairs - June, 2021
Category: Science & Technology Current Affairs
Topics: Coronavirus • COVAXIN • COVID-19 • COVID-19 vaccine • Covishield • SPUTNIK V • ZyCov-D
Vaccine Prices capped for Private Hospitals
Union Health Ministry has capped the price for administration of Covid-19 vaccines in private hospitals. Key Points Maximum price for Covaxin was fixed at Rs 1,400. Covishield will cost Rs 780 per dose, while Sputnik V vaccine will cost Rs 1,145 per dose. Strict action will be taken against private vaccination centres for overcharging. Apart ..
Month: Current Affairs - June, 2021
Category: India Nation & States Current Affairs
Topics: Corbevax vaccine • COVAXIN • COVID-19 • COVID-19 vaccine • COVISHILED • Global Covid-19 Vaccination Plan • Price Cap on vaccines
COVISHIELD: Gap between doses increased
The Government of India recently increased the gap between the two doses of the COVISHIELD Vaccine. The gap was increased from six to eight weeks to twelve to sixteen weeks. This is the second time in three months, the gaps between the doses of COVISHIELD have been widened. In March 2021, the Union Territories and ..
Month: Current Affairs - May, 2021
Category: India Nation & States Current Affairs
Topics: adenovirus • COVAXIN • COVID-19 vaccine • Covishield • Lancet • NEGVAC
Sinopharm Vaccine approved by WHO
The World Health Organisation recently approved the Emergency Use of Sinpharm vaccine. Recently, the WHO approved COVID-19 vaccines developed by AstraZeneca, Pfizer, BioNTech, Johnson and Johnson as well. The other popular Chinese Vaccine is sinovac. Sinopharm Vaccine Sinopharm vaccine was developed by China. This is the first time the WHO has given approval to a ..
Month: Current Affairs - May, 2021
Category: International Current Affairs
Topics: COVAXIN • COVID-19 vaccine • Covishield • Emergency Use Authorisation • Pfizer • Sinopharm • Sinovac • WHO